U.S. Pharmaceutical Sales - Q2 2012
The following is a list of the top 100 prescribed medicines by U.S. National Sales in Q2 2012. Figures include sales through both retail and hospital channels, listed by drug name and sales value in U.S. dollars.
Last updated: February 2014 (updated quarterly).
Top 100 drugs for Q2 2012 by sales
- Sales Statistics Q2 2012
- Units*
Rank |
Drug |
Sales ($000) |
|
|
1 ( 1) |
Nexium AstraZeneca |
1,380,413 |
-1.12% |
Stats |
2 ( 1) |
Abilify Otsuka Pharmaceutical Co., Ltd |
1,379,149 |
2.91% |
Stats |
3 ( 1) |
Singulair Merck |
1,287,806 |
4.01% |
Stats |
4 ( 2) |
Advair Diskus GlaxoSmithKline |
1,124,985 |
-1.25% |
Stats |
5 ( 2) |
Crestor AstraZeneca |
1,124,702 |
0.61% |
Stats |
6 ( 2) |
Cymbalta
|
1,057,821 |
2.77% |
Stats |
7 ( 3) |
Humira AbbVie Inc. |
1,015,639 |
9.43% |
Stats |
8 ( 4) |
Enbrel Amgen Inc. |
948,119 |
6.51% |
Stats |
9 ( 8) |
Plavix
|
934,731 |
-42.33% |
Stats |
10 ( 1) |
Remicade Janssen Pharmaceuticals, Inc. |
933,255 |
3.76% |
Stats |
11 ( 2) |
Neulasta Amgen Inc. |
842,628 |
-0.86% |
Stats |
12 ( 3) |
Rituxan Genentech, Inc. |
819,418 |
8.26% |
Stats |
13 ( 3) |
Copaxone Teva Pharmaceuticals USA, Inc. |
798,336 |
6.65% |
Stats |
14 ( 5) |
atorvastatin Generic |
784,007 |
-17.68% |
Stats |
15 ( 3) |
OxyContin Purdue Pharma LP |
683,693 |
3.14% |
Stats |
16 ( 1) |
Atripla Gilead Sciences, Inc. |
683,070 |
-1.70% |
Stats |
17 ( 2) |
Spiriva Boehringer Ingelheim Pharmaceuticals, Inc. |
661,211 |
0.21% |
Stats |
18 ( 2) |
Avastin Genentech, Inc. |
647,721 |
2.46% |
Stats |
19 ( 3) |
Januvia Merck |
605,840 |
3.81% |
Stats |
20 ( 6) |
Lipitor
|
579,297 |
-31.09% |
Stats |
21 |
Actos Takeda Pharmaceutical Company Limited |
574,553 |
-8.94% |
Stats |
22 ( 5) |
Epogen Amgen Inc. |
554,848 |
13.33% |
Stats |
23 |
Truvada Gilead Sciences, Inc. |
542,835 |
-0.60% |
Stats |
24 |
Lantus Sanofi |
529,983 |
1.81% |
Stats |
25 |
Diovan Novartis Pharmaceuticals Corporation |
490,315 |
-3.79% |
Stats |
26 ( 3) |
Lantus Solostar Sanofi |
481,022 |
7.28% |
Stats |
27 ( 3) |
enoxaparin Generic |
461,889 |
4.44% |
Stats |
28 |
Lyrica
|
454,575 |
-0.78% |
Stats |
29 ( 2) |
Eloxatin Sanofi |
454,567 |
5.24% |
Stats |
30 ( 3) |
Herceptin Genentech, Inc. |
454,063 |
6.67% |
Stats |
31 ( 1) |
Celebrex
|
437,140 |
1.43% |
Stats |
32 ( 46) |
escitalopram Generic |
416,370 |
98.11% |
Stats |
33 ( 6) |
Avonex Biogen |
414,293 |
6.61% |
Stats |
34 ( 4) |
Gleevec Novartis Pharmaceuticals Corporation |
411,455 |
5.21% |
Stats |
35 ( 2) |
Namenda Allergan plc |
407,937 |
4.16% |
Stats |
36 ( 2) |
Diovan HCT Novartis Pharmaceuticals Corporation |
402,445 |
-3.14% |
Stats |
37 ( 2) |
Lucentis Genentech, Inc. |
389,387 |
-4.92% |
Stats |
38 ( 2) |
Vyvanse Takeda Pharmaceutical Company Limited |
375,563 |
-3.00% |
Stats |
39 ( 4) |
OneTouch
|
362,111 |
-1.14% |
Stats |
40 ( 2) |
Incivek Vertex Pharmaceuticals Incorporated |
360,525 |
-2.91% |
Stats |
41 ( 4) |
methylphenidate Generic |
346,906 |
2.88% |
Stats |
42 ( 2) |
Suboxone
|
342,816 |
1.17% |
Stats |
43 ( 3) |
Zetia Merck |
336,926 |
2.52% |
Stats |
44 ( 3) |
AndroGel AbbVie Inc. |
326,838 |
4.81% |
Stats |
45 ( 4) |
Lidoderm Endo Pharmaceuticals Inc. |
305,673 |
1.43% |
Stats |
46 ( 5) |
Symbicort AstraZeneca |
294,803 |
1.42% |
Stats |
47 ( 11) |
Procrit Janssen Pharmaceuticals, Inc. |
292,501 |
10.72% |
Stats |
48 ( 2) |
TriCor AbbVie Inc. |
291,015 |
-2.62% |
Stats |
49 ( 13) |
Rebif EMD Serono, Inc. |
283,208 |
9.73% |
Stats |
50 ( 9) |
Alimta Eli Lilly and Company |
280,190 |
6.53% |
Stats |
51 ( 4) |
amphetamine/dextroamphetamine Generic |
275,171 |
-0.10% |
Stats |
52 ( 4) |
Nasonex Merck |
272,661 |
-0.76% |
Stats |
53 ( 1) |
Combivent Boehringer Ingelheim Pharmaceuticals, Inc. |
270,254 |
-5.34% |
Stats |
54 ( 3) |
Novolog Novo Nordisk |
270,047 |
1.41% |
Stats |
55 ( 1) |
Seroquel XR AstraZeneca |
268,071 |
-5.08% |
Stats |
56 ( 4) |
Viagra
|
256,066 |
-1.77% |
Stats |
57 ( 11) |
Levemir Novo Nordisk |
255,344 |
6.58% |
Stats |
58 ( 15) |
metoprolol Generic |
251,955 |
8.89% |
Stats |
59 ( 5) |
Niaspan AbbVie Inc. |
251,071 |
-1.69% |
Stats |
60 ( 7) |
Lovaza GlaxoSmithKline |
244,963 |
2.13% |
Stats |
61 ( 5) |
Flovent HFA GlaxoSmithKline |
243,193 |
0.68% |
Stats |
62 ( 8) |
Neupogen Amgen Inc. |
242,012 |
1.50% |
Stats |
63 ( 11) |
NovoLog FlexPen Novo Nordisk |
241,972 |
6.49% |
Stats |
64 ( 11) |
ProAir HFA Teva Pharmaceuticals USA, Inc. |
238,874 |
-16.08% |
Stats |
65 ( 6) |
Reyataz Bristol-Myers Squibb Company |
233,330 |
-2.02% |
Stats |
66 ( 1) |
Humalog Eli Lilly and Company |
232,698 |
-4.86% |
Stats |
67 ( ) |
modafinil Generic |
230,253 |
n/a |
Stats |
68 ( 9) |
Isentress Merck |
227,514 |
7.56% |
Stats |
69 ( 3) |
Aranesp Amgen Inc. |
223,161 |
-3.66% |
Stats |
70 ( 6) |
Janumet Merck |
217,003 |
2.07% |
Stats |
71 ( 4) |
Vytorin Merck |
215,274 |
-1.35% |
Stats |
72 ( 3) |
Adderall XR Takeda Pharmaceutical Company Limited |
214,713 |
-10.20% |
Stats |
73 ( 6) |
Cialis Eli Lilly and Company |
207,651 |
0.32% |
Stats |
74 ( 11) |
Velcade Takeda Pharmaceutical Company Limited |
203,741 |
8.04% |
Stats |
75 ( 11) |
Restasis Allergan plc |
202,233 |
7.28% |
Stats |
76 ( 5) |
Pradaxa Boehringer Ingelheim Pharmaceuticals, Inc. |
201,327 |
0.13% |
Stats |
77 ( ) |
Varivax Merck |
200,962 |
n/a |
Stats |
78 ( 5) |
fentanyl Generic |
197,539 |
0.10% |
Stats |
79 ( 1) |
Aciphex Eisai Inc. |
195,946 |
-3.52% |
Stats |
80 ( 9) |
Prezista Janssen Pharmaceuticals, Inc. |
194,476 |
6.35% |
Stats |
81 ( 18) |
budesonide Generic |
192,961 |
-24.99% |
Stats |
82 ( 15) |
Orencia Bristol-Myers Squibb Company |
191,537 |
11.23% |
Stats |
83 ( 5) |
acetaminophen/hydrocodone Generic |
190,298 |
2.66% |
Stats |
84 ( 8) |
Prevnar 13 Pfizer Inc. |
188,578 |
5.30% |
Stats |
85 ( ) |
Mirena Bayer HealthCare Pharmaceuticals Inc. |
187,854 |
n/a |
Stats |
86 ( 9) |
VESIcare Astellas Pharma US, Inc. |
183,839 |
5.34% |
Stats |
87 ( ) |
Gilenya Novartis Pharmaceuticals Corporation |
182,611 |
n/a |
Stats |
88 ( 10) |
Betaseron Bayer HealthCare Pharmaceuticals Inc. |
181,439 |
5.40% |
Stats |
89 ( 2) |
Lunesta Sunovion Pharmaceuticals Inc. |
179,192 |
-4.66% |
Stats |
90 ( 10) |
Dexilant Takeda Pharmaceutical Company Limited |
176,733 |
3.24% |
Stats |
91 |
Zyvox Pfizer Inc. |
174,134 |
-3.00% |
Stats |
92 ( ) |
Evista
|
172,894 |
n/a |
Stats |
93 ( 1) |
Benicar Daiichi Sankyo |
172,324 |
-1.31% |
Stats |
94 ( ) |
Renvela Sanofi |
171,055 |
n/a |
Stats |
95 ( 4) |
Erbitux Eli Lilly and Company |
167,914 |
-2.10% |
Stats |
96 ( ) |
Xeloda Genentech, Inc. |
167,560 |
n/a |
Stats |
97 ( ) |
Synthroid AbbVie Inc. |
165,049 |
n/a |
Stats |
98 ( ) |
Victoza Novo Nordisk |
164,409 |
n/a |
Stats |
99 ( 3) |
Ventolin HFA GlaxoSmithKline |
160,832 |
-6.88% |
Stats |
100 ( 95) |
Seroquel AstraZeneca |
159,858 |
-86.23% |
Stats |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.